Document is current
Any future updates will be listed below
-
Authors
Legrand, Melanie Alice https://orcid.org/0000-0002-1813-3368
Clemeno, Franz Aaron https://orcid.org/0009-0008-6408-4182
Chapurlat, Roland
Irani, Anushka https://orcid.org/0000-0002-7831-4208
Javaid, Muhammad Kassim https://orcid.org/0000-0001-7985-0048
-
Funding
Funding for this research was provided by:
Société Française de Rhumatologie (Société Française de Rhumatologie (SFR))
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 26 November 2025
First Online: 29 January 2026
Declarations
:
: The RUDY study received ethical approval (RUDY LREC 14/SC/0126 and 17/SC/0501), and all participants provided informed consent for data use in research.
: Not applicable.
: AI reports support from UCB outside the submitted work. FC have no disclosure. MAL reports support from Novartis and BMS outside the submitted work. MKJ reports support from Amgen, UCB, Sanofi, Kyowa Kirin, Nanox-AI, Naitive Technologies, Thornton Ross, Theramex outside the submitted work. RC reports support or honoraria from Abbvie, Amgen, UCB, Lilly, Mereo, Alexion, Amolyt, Kyowa-Kirin, Pfizer, Alfasigma, Medac, Nordic, Theramex, Novartis, Viatris, and Fresenius-Kabi outside the submitted work.
